A law firm is urging Alphabet (GOOGL) shareholders to come forward before an early-December deadline in a securities class action. The notice is a solicitation from Rosen Law Firm, not a court ruling. Alphabet shares traded at 295.77 USD on the latest quote (Nov. 13, 2026), a change of -0.98% on the day.
What it is
According to the Rosen release dated Nov. 13, 2026, the firm is reminding people who bought Alphabet securities during a defined "class period" that a lead plaintiff deadline is coming. The class period runs from late spring to mid-summer 2026.
A lead plaintiff is the investor the court picks to steer a class action for everyone else. The release says eligible buyers may be entitled to compensation through a contingency fee arrangement. That means no out-of-pocket fees or costs for the investor, according to the firm.
This kind of notice is routine. Several law firms often issue near-identical reminders for the same case.
What it is not
It is not a finding that Alphabet did anything wrong. A class action starts with allegations, and a court has made no ruling on them.
It is also not a settlement, and the release gives no payout. It is a marketing notice from a law firm that wants clients. Nothing in it changes how Alphabet reports its results or runs its business.
Who it affects
It matters mainly to people who bought Alphabet shares during the class period and want to consider taking part. Holders outside that window are not covered by the notice.
For the business, the latest reported numbers are the better guide. In the third quarter ended Sept. 30, 2026, Alphabet reported revenue of $127.58B, higher than a year earlier by 24.7%. Revenue was slightly below the analyst estimate of $128.00B.
Earnings per share were 2.12, against an analyst estimate of 3.02, a difference of -$0.90, or -29.8%. Net income was $26.47B, down 24.3% from the year-ago quarter.
Cash flow was also negative that quarter. Free cash flow was -$9.06B, with operating cash flow of $42.29B. Alphabet held $265.10B in cash and short-term investments, and FMP reports net debt of $85.58B.
Our MoonshotScore for Alphabet is 91, with safety its strongest section and valuation its weakest.
What to watch next
- Early December 2026: the lead plaintiff deadline named in the release. After that, a court typically picks a lead plaintiff.
- Feb. 3, 2027: Alphabet's next earnings date, 82 days after the latest quote. The EPS estimate is 3.14 and the revenue estimate is $142.52B.
- Any company response: the release does not include one. Watch for Alphabet's own filings or statements on the case.
Key facts
- Nov. 13, 2026: shares traded at 295.77 USD on the latest quote, a change of -0.98%.
- The share price is 27.6% below its 52-week high of 408.61 USD and 9.3% above its 52-week low of 270.7 USD.
- Oct. 28, 2026: Alphabet reported third-quarter EPS of 2.12 against an estimate of 3.02.
- Analyst consensus price target: average 402.77 USD, ranging from a low of 325.00 USD to a high of 485.00 USD. Of 83 ratings, the consensus is "Buy".
- In the last 90 days, FMP lists 0 open-market insider purchases and 1 sale among the filings it checked.
| Metric | Q3 FY2026 | Q3 FY2025 |
|---|---|---|
| Revenue | $127.58B | $102.35B |
| Operating income | $40.58B | $31.23B |
| Net income | $26.47B | $34.98B |
| Diluted EPS | 2.12 | 2.87 |
Frequently asked questions
Q: Is there a class action against Alphabet?
According to the Rosen Law Firm release, a securities class action covers a class period in mid-2026. The release is a lead plaintiff reminder. It does not report any ruling on the claims.Q: Does the lawsuit notice mean Alphabet will pay damages?
No. The notice announces no settlement or verdict. Allegations in a class action are unproven unless a court decides otherwise or the parties settle.Q: What was Alphabet's latest earnings result?
In the third quarter ended Sept. 30, 2026, Alphabet reported EPS of 2.12 against an analyst estimate of 3.02. Revenue was $127.58B against an estimate of $128.00B.This is educational content, not investment advice. Past performance does not guarantee future results.
